ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事关于第五届董事会第十九次会议相关事项的独立意见 | 2022-06-02 | Chinese | |
| 关于开展外汇套期保值业务的公告 | 2022-06-02 | Chinese | |
| 第五届董事会第十九次会议决议公告 | 2022-06-02 | Chinese | |
| 第五届监事会第十五次会议决议公告 | 2022-06-02 | Chinese | |
| 北京国枫律师事务所关于睿智医药科技股份有限公司2021年限制性股票激励计划作废部分限制性股票的法律意见书 | 2022-06-02 | Chinese | |
| 上海荣正投资咨询股份有限公司关于睿智医药科技股份有限公司2021年限制性股票激励计划作废部分限制性股票相关事项之独立财务顾问报告 | 2022-06-02 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 36037863 | 独立董事关于第五届董事会第十九次会议相关事项的独立意见 | 2022-06-02 | Chinese | ||
| 36037851 | 关于开展外汇套期保值业务的公告 | 2022-06-02 | Chinese | ||
| 36037842 | 第五届董事会第十九次会议决议公告 | 2022-06-02 | Chinese | ||
| 36037837 | 第五届监事会第十五次会议决议公告 | 2022-06-02 | Chinese | ||
| 36037828 | 北京国枫律师事务所关于睿智医药科技股份有限公司2021年限制性股票激励计划作废部分限制性股票的法律意见书 | 2022-06-02 | Chinese | ||
| 36037822 | 上海荣正投资咨询股份有限公司关于睿智医药科技股份有限公司2021年限制性股票激励计划作废部分限制性股票相关事项之独立财务顾问报告 | 2022-06-02 | Chinese | ||
| 36037815 | 关于开展外汇套期保值业务可行性分析报告 | 2022-06-02 | Chinese | ||
| 36037809 | 关于作废2021年限制性股票激励计划部分已授予尚未归属的第二类限制性股票的公告 | 2022-06-02 | Chinese | ||
| 36037802 | 关于出售量子高科（广东）生物有限公司股权的进展公告 | 2022-05-31 | Chinese | ||
| 36037795 | 关于对深圳证券交易所2021年年报问询函的回复公告 | 2022-05-30 | Chinese | ||
| 36037765 | 安永华明会计师事务所（特殊普通合伙）关于睿智医药年报问询函的专项说明 | 2022-05-30 | Chinese | ||
| 36037739 | 2021年年度股东大会决议公告 | 2022-05-23 | Chinese | ||
| 36037728 | 2021年年度股东大会法律意见书 | 2022-05-23 | Chinese | ||
| 36037717 | 关于变更2021年年度股东大会现场会议地点的公告 | 2022-05-16 | Chinese | ||
| 36037708 | 关于举行2021年度网上业绩说明会的公告 | 2022-05-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.